Cargando…
A novel classification based on B-cell receptor signal gene expression correlates with prognosis in primary breast diffuse large B-cell lymphoma
Primary breast diffuse large B-cell lymphoma (PB-DLBCL), the most common histologic subtype of lymphoid malignancy in the breast, is a clinically and genetically heterogeneous disease that has insufficient systematic studies on the pathological and molecular features, optimal treatment scheme, as we...
Autores principales: | Su, Wenjia, Niu, Xingjian, Ji, Hongfei, Xu, Yang, Zhong, Lei, Wang, Shuye, Tang, Dabei, Zhou, Xiaoping, Zhang, Qingyuan, Zhou, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066002/ https://www.ncbi.nlm.nih.gov/pubmed/32201514 http://dx.doi.org/10.7150/jca.39083 |
Ejemplares similares
-
Helicobacter pylori infection disturbs the tumor immune microenvironment and is associated with a discrepant prognosis in gastric de novo diffuse large B-cell lymphoma
por: Deng, Yuwei, et al.
Publicado: (2021) -
Influence of Hyperglycemia on the Prognosis of Patients with Diffuse Large B-Cell Lymphoma
por: Zhou, Weiling, et al.
Publicado: (2022) -
Molecular classification and therapeutics in diffuse large B-cell lymphoma
por: Shimkus, Gaelen, et al.
Publicado: (2023) -
microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma
por: Larrabeiti-Etxebarria, Ane, et al.
Publicado: (2023) -
Body Composition as a Predictor of Toxicity and Prognosis in Patients with Diffuse Large B-Cell Lymphoma Receiving R-CHOP Immunochemotherapy
por: Guo, Jiaxun, et al.
Publicado: (2021)